Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8937349 | British Journal of Anaesthesia | 2009 | 7 Pages |
Abstract
The target plasma concentration for fibrinogen replacement was predicted by these in vitro results to be greater than 200 mg dlâ1 as only these concentrations optimized the rate of clot formation. This concentration is twice the level suggested by the current transfusion guidelines. Although improved, clots were prone to fibrinolysis indicating that the efficacy of fibrinogen therapy may be influenced by co-existing fibrinolytic tendency occurring during dilutional coagulopathy.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
D. Bolliger, F. Szlam, R.J. Molinaro, N. Rahe-Meyer, J.H. Levy, K.A. Tanaka,